GlobeImmune Stock Price (OTCMKTS:GBIM)

Add to My Stocks
$0.6 $0.1 (14.29%) GBIM stock closing price Mar 16, 2018 (Closing)
Prev Close* : $0.7
Market Cap:
Day Low: $0.6
52 Week Low: $0.20
Open: $0.6
Volume: $784
Day High: $0.6
52 Week High: $0.90

Latest Stock Market News

Latest Articles

GlobeImmune News - From Partners

GBIM Stockcharts

View GBIM PE ratio, PS ratio stocks charts and compare with peers.
GBIM Chart
Note: Compare GlobeImmune stock price history with the index and industry peers.

GlobeImmune Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

GlobeImmune Returns

(return on equity)

GlobeImmune Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

GBIM Industry Peers

Company Price Change (%)
Acura Pharma (ACUR)0.540 (0%)
Parnell Pharma (PARNF)0.310.01 (3.13%)
Bristol-myers Squibb (BMY)66.60.35 (0.53%)
Amgen (AMGN)188.241.51 (0.8%)
Johnson & Johnson (JNJ)133.680.62 (0.47%)
Newlink Genetics (NLNK)7.240.12 (1.63%)
Alnylam Pharma (ALNY)145.063.68 (2.6%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Teligent (TLGT)30.52 (20.97%)
Supernus Pharma (SUPN)44.71.53 (3.54%)
Corium (CORI)11.560.34 (3.03%)
Adamas Pharma (ADMS)27.10.65 (2.46%)
Mallinckrodt (MNK)16.090.32 (2.03%)
Teva Pharmaceutical (TEVA)18.370.32 (1.77%)
Allergan (AGN)168.962.84 (1.71%)
Top gainers from Medical-Generic Drugs industry
* As of Mar 17, 2018
CompanyPriceChange (%)
Agile Therapeutics (AGRX)3.030.16 (5.02%)
Dr. Reddy's Laboratories (RDY)33.160.9 (2.64%)
AEVI GENOMIC (GNMX)2.040.03 (1.45%)
Top losers from Medical-Generic Drugs industry
* As of Mar 17, 2018

GlobeImmune Inc Stock News - Partner Headlines

GlobeImmune Financial Statements

income statement2015201420132012
Net Sales or Revenues6.45M5.96M22.51M14.64M
Net Income-2.76M-16.26M9.47M-2.01M
Total Operating Expense6.38M6.49M5.03M7.64M
View GlobeImmune income statement
balance sheet2015201420132012
Total Assets11.5M18.36M7.41M-
Total Liabilities8.51M12.76M19.05M-
Shareholders Equity2.98M5.6M-11.63M-
View GlobeImmune balance sheet
cash flow statement2015201420132012
Net Increase (Decrease) in Assets Liabilities-4.54M-4.52M-4.69M-10.39M
Net Cash from (used by) Operating Activities-7.12M-10.05M3.93M-13.06M
Increase (Decrease) in Prop Plant And Equipment--0.16M-0.01M-0.1M
View GlobeImmune cash flow statement

GlobeImmune Stock Message Board

As of last trading day, GlobeImmune stock price was $0.6. GlobeImmune market capitalization is $3.45M and it represents the total market value of GBIM stock. A value investor must look at the fundamentals of a stock, and perform GlobeImmune valuation, even though in the short-term, sentiment and current breaking news might affect GlobeImmune stock price.

For recognizing and analyzing the real performance of GlobeImmune stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 784 GBIM shares were traded yesterday, and GlobeImmune stock chart shows that the GBIM stock quote hit a day high of $0.6 and day low of $0.6. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. GlobeImmune does not pay dividends. One can observe stock price trends and check for volatility by checking GlobeImmune stock price history.